Literature DB >> 35365799

Re-evaluating hypertension in children according to different guidelines: a single-center study.

Cemaliye Basaran1, Belde Kasap Demir2,3, Mustafa Agah Tekindal4, Gokcen Erfidan2, Ozgur Ozdemir Simsek2, Secil Arslansoyu Camlar5, Caner Alparslan2, Demet Alaygut5, Fatma Mutlubas5, Ferhan Elmali4.   

Abstract

We aimed to evaluate the agreements between the guidelines used for both office blood pressure (OBP) and ambulatory blood pressure monitoring (ABPM). Our secondary aim was to define the best threshold to assess children at risk of left ventricular hypertrophy (LVH). Thresholds proposed by the Fourth Report (FR), European Society of Hypertension (ESH), and American Academy of Pediatrics (AAP) for OBP and the Wühl, ESH, and American Heart Association (AHA) for ABPM were used, and nine different BP phenotype combinations were created. The agreements between the thresholds, the sensitivity of the thresholds, and the BP phenotypes used to predict LVH were determined in 949 patients with different ages and body mass indices (BMIs). The agreements between the guidelines for OBP and ABPM were "good" and "very good" (κ = 0.639; 95% CI, 0.638-0.640, κ = 0.986; 95% CI, 0.985-0.988), respectively. To classify OBP and ABPM into BP phenotypes, we obtained nine different combinations, which had "very good" agreement (κ = 0.880; 95% CI, 0.879-0.880). The sensitivity of AAP for detecting LVH was the highest in <12-year-old obese children (S = 75.8, 95% CI, 56.4-89.7). The sensitivity of ABPM in detecting LVH was similar among different age and BMI groups. The sensitivity of different BP phenotypes tended to be higher in the groups where OBP was evaluated according to AAP. The highest sensitivity was detected in the 13- to 15-year-old normal weight group.(S: 88.8, 95% CI, 51.7-99.7). The AAP guideline is more sensitive and decisive for BP phenotypes to detect LVH, especially in normal-weight children ≤ 15 years, while ABPM thresholds for children have limited effect.
© 2022. The Author(s), under exclusive licence to The Japanese Society of Hypertension.

Entities:  

Keywords:  Adolescence; Ambulatory blood pressure monitoring; Guideline; Left ventricular hypertrophy; hypertension

Mesh:

Year:  2022        PMID: 35365799     DOI: 10.1038/s41440-022-00896-2

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  24 in total

1.  Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions.

Authors:  Elke Wühl; Klaus Witte; Marianne Soergel; Otto Mehls; Franz Schaefer
Journal:  J Hypertens       Date:  2002-10       Impact factor: 4.844

2.  Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.

Authors:  Denis L Clement; Marc L De Buyzere; Dirk A De Bacquer; Peter W de Leeuw; Daniel A Duprez; Robert H Fagard; Peter J Gheeraert; Luc H Missault; Jacob J Braun; Roland O Six; Patricia Van Der Niepen; Eoin O'Brien
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

3.  Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents.

Authors:  Joseph T Flynn; David C Kaelber; Carissa M Baker-Smith; Douglas Blowey; Aaron E Carroll; Stephen R Daniels; Sarah D de Ferranti; Janis M Dionne; Bonita Falkner; Susan K Flinn; Samuel S Gidding; Celeste Goodwin; Michael G Leu; Makia E Powers; Corinna Rea; Joshua Samuels; Madeline Simasek; Vidhu V Thaker; Elaine M Urbina
Journal:  Pediatrics       Date:  2017-08-21       Impact factor: 7.124

4.  Prevalence, persistence, and clinical significance of masked hypertension in youth.

Authors:  Empar Lurbe; Isabel Torro; Vicente Alvarez; Tim Nawrot; Rafael Paya; Josep Redon; Jan A Staessen
Journal:  Hypertension       Date:  2005-03-14       Impact factor: 10.190

Review 5.  Pediatric Hypertension: Diagnosis, Evaluation, and Treatment.

Authors:  Monica Guzman-Limon; Joshua Samuels
Journal:  Pediatr Clin North Am       Date:  2019-02       Impact factor: 3.278

6.  2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents.

Authors:  Empar Lurbe; Enrico Agabiti-Rosei; J Kennedy Cruickshank; Anna Dominiczak; Serap Erdine; Asle Hirth; Cecilia Invitti; Mieczyslaw Litwin; Giuseppe Mancia; Denes Pall; Wolfgang Rascher; Josep Redon; Franz Schaefer; Tomas Seeman; Manish Sinha; Stella Stabouli; Nicholas J Webb; Elke Wühl; Alberto Zanchetti
Journal:  J Hypertens       Date:  2016-10       Impact factor: 4.844

7.  Diagnosis of hypertension in children and adolescents based on home versus ambulatory blood pressure monitoring.

Authors:  George S Stergiou; Efthimia Nasothimiou; Periklis Giovas; Anastasios Kapoyiannis; Adriani Vazeou
Journal:  J Hypertens       Date:  2008-08       Impact factor: 4.844

8.  Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association.

Authors:  Joseph T Flynn; Stephen R Daniels; Laura L Hayman; David M Maahs; Brian W McCrindle; Mark Mitsnefes; Justin P Zachariah; Elaine M Urbina
Journal:  Hypertension       Date:  2014-03-03       Impact factor: 10.190

9.  White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study.

Authors:  Sam S E Sivén; Teemu J Niiranen; Ilkka M Kantola; Antti M Jula
Journal:  J Hypertens       Date:  2016-01       Impact factor: 4.844

Review 10.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.